PlainRecalls

Becton Dickinson & Co.

185 recalls on record · Latest: May 6, 2026

Subscribe to new Becton Dickinson & Co. recalls (RSS)

Agency notice ledger

Federal filing book Becton Dickinson & Co. HEAVY-BOOK · SINGLE-AGENCY

#83 of 14,151 · 185 notices · 0.177% archive

  • BOOK 185 notices
  • RANK #83 of 14,151
  • SHARE 0.177% archive
  • AGENCY FDA Devices (185)
  • CAT medical devices
  • CATS 1 category
  • LATEST May 6, 2026
  • PHOTO Chevrolet

Nearest notice-volume peer: Chevrolet (2 notice gap)

Becton Dickinson & Co. accounts for about 0.177% of the 104,423-notice archive on 185 distinct filings — a heavy share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Becton Dickinson & Co.'s standing among 14,151 recalling firms

Becton Dickinson & Co. ranks 83rd of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Becton Dickinson & Co. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

185 83rd of 14151 higher than 14,068 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Becton Dickinson & Co. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Becton Dickinson & Co. holds about 0.177% of archive notices alongside 185 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Devices Moderate May 6, 2026

BD GasPak EZ CO2 Pouch System. Catalog Number: 260684. for microbiologic use

FDA Devices Moderate May 6, 2026

BD GasPak EZ Campy Pouch System. Catalog Number: 260685. for microbiologic use

FDA Devices Moderate Nov 19, 2025

BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100;

FDA Devices Moderate Oct 29, 2025

BD EpiCenter Microbiology Data Management System, labeled as the following: 1. Computer System Epicenter F/G, Catalog Number: 441002. 2. COMPUTER OPTIPLEX EPICENTER SPARE, Catalog Number: 441421. 3. Generic NUC 2, Catalog Number: 445398. 4. Nuc 5i5 Os Image Bow 2.X, Catalog Number: 443971.

FDA Devices Moderate Oct 29, 2025

BD BACTEC Blood Culture System, labeled as the following: 1. BACTEC 9120 System, Catalog Numbers: 445570, 445702. 2. INSTRUMENT BACTEC 9120 UNREPAIRED, Catalog Number: 44557008.

FDA Devices Moderate Oct 29, 2025

BD Veritor Connect Software, labeled as the following: 1. Veritor (NUC), Catalog Number: 444881. Transfers in vitro diagnostic results data on the BD Veritor Plus Analyzer to BD Synapsys.

FDA Devices Moderate Oct 29, 2025

BD BACTEC Blood Culture System, labeled as the following: 1. BD BACTEC FX, Instrument Top, Packaged, Catalog Number: 44138509. 2. Instrument Top Remanufactured Bactec Fx, Catalog Number: 441676. 3. BACTEC 9240 System, Catalog Number: 445569. 4. BD BACTEC FX40 Instrument, Catalog Number: 44229609.

FDA Devices Moderate Oct 29, 2025

BD MAX System, for in vitro diagnostic (IVD) use, labeled as the following: 1. BD MAX System, BD MAX Instrument, Catalog Numbers: 44191609, 441927.

FDA Devices Moderate Oct 29, 2025

BD Phoenix M50 Instrument, labeled as the following: 1. BD Phoenix M50 Automated Microbiology System, Catalog Numbers: 443624, 44362409.

FDA Devices Moderate Jul 30, 2025

BD COR System Software. Model Number: 444829.

FDA Devices Moderate Jul 2, 2025

BD BACTEC MGIT 960 PZA Kit. IVD qualitative procedure for susceptibility testing of Mycobacterium tuberculosis, from culture to pyrazinamide (PZA).

FDA Devices Moderate Mar 12, 2025

BD BBL TB Stain Kit K, Catalog (REF): 212522

FDA Devices Moderate Jan 29, 2025

BD PCR Cartridges used with MAX System. Model Number: 437519

FDA Devices Moderate Dec 11, 2024

BD COR GX Instrument Version or Model: 443990 Catalog Number: 443990

FDA Devices Moderate Dec 11, 2024

BD Synapsys Informatics Solution (Laboratory Solution) Version or Model: 444150 Catalog Number: 444150

FDA Devices Moderate Dec 11, 2024

BD MAX System, BD MAX Instrument Version or Model: 441916 Catalog Number: 441916

FDA Devices Moderate Dec 11, 2024

BD BACTEC FX, Instrument Top, Packaged Version or Model: 441385 Catalog Number: 441385

FDA Devices Moderate Dec 11, 2024

BD EpiCenter Single User Software Version or Model: 441007 Catalog Number: 441007

FDA Devices Moderate Dec 11, 2024

BD EpiCenter Data Management System, Multi User Software Version or Model: 440981 Catalog Number: 440981

FDA Devices Moderate Dec 11, 2024

BACTEC 9240 System Version or Model: 445475 Catalog Number: 445475

FDA Devices Moderate Dec 11, 2024

BD COR MX Instrument Version or Model: 443989 Catalog Number: 443989

FDA Devices Moderate Dec 11, 2024

BD EpiCenter Data Management System Version or Model: 440887 Catalog Number: 440887

FDA Devices Moderate Dec 11, 2024

BD COR PX Instrument Version or Model: 443988 Catalog Number: 443988

FDA Devices Moderate Dec 11, 2024

BD BACTEC FX40 Instrument Version or Model: 442296 Catalog Number: 442296

FDA Devices Moderate Dec 11, 2024

BD BBL Sensi Disc Ampicillin 2 ¿g (AM-2) - In-Vitro BD BBL Sensi Disc Ampicillin 2 ¿g (AM-2) are used for semi-quantitative in vitro susceptibility testing by the agar disc diffusion test procedure of common, rapidly growing and certain fastidious bacterial pathogens. Catalog Number: 231263

FDA Devices Moderate Dec 11, 2024

BACTEC 9120 System Version or Model: 445570 Catalog Number: 445570

FDA Devices Moderate Dec 11, 2024

BD Phoenix M50 Automated Microbiology System Version or Model: 443624 Catalog Number: 443624

FDA Devices Moderate Oct 16, 2024

BD Synapsys Informatics Solution with software versions: 4.20, 4.30, 5.10, 5.20 and 5.30- IVD standalone laboratory software solution providing data management and workflow management functionality across locations where clinical diagnostic activities take place. Catalog Number: 444150

FDA Devices Moderate Oct 2, 2024

BD Phoenix M50 instrument -Intended for the rapid identification (ID) and antimicrobial susceptibility testing (AST) of clinically significant bacteria. The BD Phoenix System provides rapid results for most aerobic and facultative anaerobic Grampositive bacteria. Catalog Number: 443624

FDA Devices Moderate Oct 2, 2024

BD Phoenix 100-Intended for the rapid identification (ID) and antimicrobial susceptibility testing (AST) of clinically significant bacteria. The BD Phoenix System provides rapid results for most aerobic and facultative anaerobic Grampositive bacteria. Catalog Number: 448100

FDA Devices Moderate Aug 28, 2024

BD BACTEC MGIT 960 PZA Kit)- IVD qualitative procedure for susceptibility testing of Mycobacterium tuberculosis, from culture to pyrazinamide (PZA) Catalog Number: 245128

FDA Devices Moderate Aug 21, 2024

BD Kiestra Urine Culture Application Powered by BD Synapsys Informatics Solution; Catalog (Ref): 444900;

FDA Devices Moderate Jun 12, 2024

BD SARS-CoV-2 Reagents for BD MAX" Systems. RT-PCR test to detect SARS-CoV-2 in nasal, nasopharyngeal, oropharyngeal swab specimens, and saliva specimens.

FDA Devices Moderate Apr 10, 2024

BD Phoenix Yeast ID Panel is a self-inoculating (when used with a BD Phoenix Automated Microbiology System) polystyrene panel (tray) containing control wells and substrate wells with dried biochemical substrates that use traditional qualitative microbiology methods such as fermentation, oxidation, degradation, and hydrolysis in combination with chromogenic and fluorogenic substrates along with carbon sources for yeast identification.

FDA Devices Moderate Apr 10, 2024

BD Phoenix NMIC-306 Panel is a self-inoculating (when used with a BD Phoenix Automated Microbiology System) polystyrene panel (tray) containing control wells and substrate wells with dried biochemical substrates that use traditional qualitative microbiology methods such as fermentation, oxidation, degradation, and hydrolysis in combination with chromogenic and fluorogenic substrates along with carbon sources for bacterial identification and quantitation.

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Piperacillin/Tazobactam- 100/10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231691 and 231692¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Azithromycin -15 ¿g, Catalog Number 231682¿used for semi-quantitative in vitro susceptibility testing.

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Rifampin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231541 and 231544¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Cefpodoxime - 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231673 and 231674¿

FDA Devices Moderate Feb 14, 2024

Sensi Disc Amoxicillin with Clavulanic Acid 20/10 ¿g, Catalog No. 231628 and 231629.¿ These discs are used for semi-quantitative in vitro susceptibility testing

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Minocycline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231250 and 231251¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Cefaclor - 30 ug¿, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231653¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Cefotaxime - 30 ug¿, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231606 and 231607¿; 5 ug, Catalog No. 291308¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Tetracycline 30 ug,used for semi-quantitative in vitro susceptibility testing. Catalog Number 230998 and 231344¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Meropenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231703 and 231704¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Ceftaroline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232231¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Cefepime - 30 ug¿, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231696¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Imipenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231644 and 231645¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Moxifloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231758¿

FDA Devices Moderate Feb 14, 2024

BD BBL Sensi Disc Chloramphenicol- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 230733¿and 231274¿

Becton Dickinson & Co. carries an outsized archive share

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (185 here — heavy-book).

Frequently Asked Questions

How many federal recall notices name Becton Dickinson & Co.?
PlainRecalls indexes 185 distinct federal recall events naming Becton Dickinson & Co., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Becton Dickinson & Co. sit among other recalling firms?
Becton Dickinson & Co. ranks #83 of 14,151 by distinct recall-event count among 14,151 firms in this archive (99th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Becton Dickinson & Co.'s notices?
FDA Devices accounts for 185 of this firm's 185 indexed notices.
What product category dominates Becton Dickinson & Co.'s filing book?
Filings for Becton Dickinson & Co. span 1 product category, led by medical devices. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous?
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Becton Dickinson & Co.: 185 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Devices). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Becton Dickinson & Co.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026